These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24863399

  • 1. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H, Yoshida N, Shinnabe A, Iino Y.
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [Abstract] [Full Text] [Related]

  • 2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [Abstract] [Full Text] [Related]

  • 3. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [Abstract] [Full Text] [Related]

  • 4. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [Abstract] [Full Text] [Related]

  • 5. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [Abstract] [Full Text] [Related]

  • 7. Role of IgE in eosinophilic otitis media.
    Iino Y.
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [Abstract] [Full Text] [Related]

  • 8. New Insights into Eosinophilic Otitis Media.
    Kanazawa H, Yoshida N, Iino Y.
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [Abstract] [Full Text] [Related]

  • 9. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y.
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [Abstract] [Full Text] [Related]

  • 10. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H, Matsuwaki Y, Kato M, Otori N, Kojima H.
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [Abstract] [Full Text] [Related]

  • 11. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Yabe T, Matsutani S.
    Clin Exp Allergy; 2001 Jul; 31(7):1135-43. PubMed ID: 11468006
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M.
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y, Takahashi E, Ida S, Kikuchi S.
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [Abstract] [Full Text] [Related]

  • 15. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [Abstract] [Full Text] [Related]

  • 16. Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation.
    Matsuwaki Y, Uno K, Okushi T, Otori N, Moriyama H.
    Int Arch Allergy Immunol; 2013 Oct; 161 Suppl 2():147-53. PubMed ID: 23711866
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics of so called eosinophilic otitis media.
    Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T.
    Auris Nasus Larynx; 2002 Jan; 29(1):19-28. PubMed ID: 11772486
    [Abstract] [Full Text] [Related]

  • 18. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
    Iino Y, Kakizaki K, Saruya S, Katano H, Komiya T, Kodera K, Ohta K.
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
    [Abstract] [Full Text] [Related]

  • 19. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion.
    Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, Yagi T.
    Acta Otolaryngol; 2003 Apr; 123(3):383-7. PubMed ID: 12737295
    [Abstract] [Full Text] [Related]

  • 20. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE, Kang YS, Cho Y, Park MK.
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.